The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...

The investigational cancer vaccine, NOUS-209, was found to safely stimulate the immune system to target precancerous and ...

A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...

The study examined 180 patients with advanced lung cancer who received a COVID vaccine within 100 days before or after beginning immunotherapy, as well as 704 similar patients who did not. Vaccinated ...

HPV vaccination offers herd immunity, and one dose is just as effective as two, as new CDC guidance reflects. The post HPV ...

The result is one molecule that can be both a checkpoint degrader and a cancer vaccine ( Nature 2026, DOI: 10.1038/s41586-025 ...

Findings from a phase I trial (NCT04183166) evaluating TG4050, a neoantigen therapeutic vaccine, in patients with operable, ...

January is Cervical Cancer Awareness Month, shining a spotlight on one of the most preventable forms of cancer thanks to the ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

During January, which is National Cervical Cancer Awareness Month, consider this fact: HPV, or human papillomavirus, causes ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...